191 related articles for article (PubMed ID: 9890001)
21. Update on basic research on Hirschsprung's disease.
Martucciello G; Holschneider AM
Eur J Pediatr Surg; 1998 Jun; 8(3):131-2. PubMed ID: 9676392
[No Abstract] [Full Text] [Related]
22. Characterization of Ret-Shc-Grb2 complex induced by GDNF, MEN 2A, and MEN 2B mutations.
Ohiwa M; Murakami H; Iwashita T; Asai N; Iwata Y; Imai T; Funahashi H; Takagi H; Takahashi M
Biochem Biophys Res Commun; 1997 Aug; 237(3):747-51. PubMed ID: 9299438
[TBL] [Abstract][Full Text] [Related]
23. [Advances in the etiology and pathogenesis of congenital megacolon].
Xia G; Xu J; Wang G
Zhonghua Wai Ke Za Zhi; 1997 Sep; 35(9):568-70. PubMed ID: 10678038
[No Abstract] [Full Text] [Related]
24. Mutation analysis of the c-mos proto-oncogene and the endothelin-B receptor gene in medullary thyroid carcinoma and phaeochromocytoma.
Eng C; Foster KA; Healey CS; Houghton C; Gayther SA; Mulligan LM; Ponder BA
Br J Cancer; 1996 Aug; 74(3):339-41. PubMed ID: 8695346
[TBL] [Abstract][Full Text] [Related]
25. The RET proto-oncogene induces apoptosis: a novel mechanism for Hirschsprung disease.
Bordeaux MC; Forcet C; Granger L; Corset V; Bidaud C; Billaud M; Bredesen DE; Edery P; Mehlen P
EMBO J; 2000 Aug; 19(15):4056-63. PubMed ID: 10921886
[TBL] [Abstract][Full Text] [Related]
26. Biological properties of Ret with cysteine mutations correlate with multiple endocrine neoplasia type 2A, familial medullary thyroid carcinoma, and Hirschsprung's disease phenotype.
Ito S; Iwashita T; Asai N; Murakami H; Iwata Y; Sobue G; Takahashi M
Cancer Res; 1997 Jul; 57(14):2870-2. PubMed ID: 9230192
[TBL] [Abstract][Full Text] [Related]
27. RET oncogene.
Mak YF; Ponder BA
Curr Opin Genet Dev; 1996 Feb; 6(1):82-6. PubMed ID: 8791480
[TBL] [Abstract][Full Text] [Related]
28. ret protooncogene mutations and endocrine neoplasia--a story intertwined with neural crest differentiation.
Gagel RF
Endocrinology; 1996 May; 137(5):1509-11. PubMed ID: 8612478
[No Abstract] [Full Text] [Related]
29. Analysis of the RET, GDNF, EDN3, and EDNRB genes in patients with intestinal neuronal dysplasia and Hirschsprung disease.
Gath R; Goessling A; Keller KM; Koletzko S; Coerdt W; Müntefering H; Wirth S; Hofstra RM; Mulligan L; Eng C; von Deimling A
Gut; 2001 May; 48(5):671-5. PubMed ID: 11302967
[TBL] [Abstract][Full Text] [Related]
30. Mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2.
Ponder BA
Cancer Surv; 1995; 25():195-205. PubMed ID: 8718519
[No Abstract] [Full Text] [Related]
31. Full activation of MEN2B mutant RET by an additional MEN2A mutation or by ligand GDNF stimulation.
Bongarzone I; Vigano E; Alberti L; Borrello MG; Pasini B; Greco A; Mondellini P; Smith DP; Ponder BA; Romeo G; Pierotti MA
Oncogene; 1998 May; 16(18):2295-301. PubMed ID: 9620546
[TBL] [Abstract][Full Text] [Related]
32. Multiple endocrine neoplasia type 2: molecular aspects.
Mulligan LM
Front Horm Res; 2001; 28():81-102. PubMed ID: 11443855
[No Abstract] [Full Text] [Related]
33. The physical map of the human RET proto-oncogene.
Pasini B; Hofstra RM; Yin L; Bocciardi R; Santamaria G; Grootscholten PM; Ceccherini I; Patrone G; Priolo M; Buys CH
Oncogene; 1995 Nov; 11(9):1737-43. PubMed ID: 7478601
[TBL] [Abstract][Full Text] [Related]
34. RET and GDNF gene scanning in Hirschsprung patients using two dual denaturing gel systems.
Hofstra RM; Wu Y; Stulp RP; Elfferich P; Osinga J; Maas SM; Siderius L; Brooks AS; vd Ende JJ; Heydendael VM; Severijnen RS; Bax KM; Meijers C; Buys CH
Hum Mutat; 2000; 15(5):418-29. PubMed ID: 10790203
[TBL] [Abstract][Full Text] [Related]
35. Germline mutations of the RET ligand GDNF are not sufficient to cause Hirschsprung disease.
Salomon R; Attié T; Pelet A; Bidaud C; Eng C; Amiel J; Sarnacki S; Goulet O; Ricour C; Nihoul-Fékété C; Munnich A; Lyonnet S
Nat Genet; 1996 Nov; 14(3):345-7. PubMed ID: 8896569
[TBL] [Abstract][Full Text] [Related]
36. Enhanced phosphatidylinositol 3-kinase activity and high phosphorylation state of its downstream signalling molecules mediated by ret with the MEN 2B mutation.
Murakami H; Iwashita T; Asai N; Shimono Y; Iwata Y; Kawai K; Takahashi M
Biochem Biophys Res Commun; 1999 Aug; 262(1):68-75. PubMed ID: 10448070
[TBL] [Abstract][Full Text] [Related]
37. Expression of RET proto-oncogene and GDNF deficit in Hirschsprung's disease.
Zhan J; Xiu Y; Gu J; Fang Z; Hu XL
J Pediatr Surg; 1999 Nov; 34(11):1606-9. PubMed ID: 10591552
[TBL] [Abstract][Full Text] [Related]
38. Sympathoadrenal hyperplasia causes renal malformations in Ret(MEN2B)-transgenic mice.
Gestblom C; Sweetser DA; Doggett B; Kapur RP
Am J Pathol; 1999 Dec; 155(6):2167-79. PubMed ID: 10595945
[TBL] [Abstract][Full Text] [Related]
39. Characterization of gene expression induced by RET with MEN2A or MEN2B mutation.
Watanabe T; Ichihara M; Hashimoto M; Shimono K; Shimoyama Y; Nagasaka T; Murakumo Y; Murakami H; Sugiura H; Iwata H; Ishiguro N; Takahashi M
Am J Pathol; 2002 Jul; 161(1):249-56. PubMed ID: 12107109
[TBL] [Abstract][Full Text] [Related]
40. Hirschsprung associated GDNF mutations do not prevent RET activation.
Borghini S; Bocciardi R; Bonardi G; Matera I; Santamaria G; Ravazzolo R; Ceccherini I
Eur J Hum Genet; 2002 Mar; 10(3):183-7. PubMed ID: 11973622
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
